This information is provided for educational purposes only and should not be considered legal advice. Employment decisions depend on numerous factors including applicable federal and state law, industry regulations, job duties, employer policies, contractual obligations, and the facts of each situation. Employers should consult qualified employment counsel before making workplace policy or disciplinary decisions.
Castellan Health Occupational Medicine Team
Occupational health and employer services review
Updated and last reviewed: July 2026. Designed for Florida and West Central Florida employers, including Tampa, Brandon, Riverview, Plant City, St Petersburg, Clearwater, Largo, Pinellas County, Hillsborough County, and Pasco County.
Short Answer for Employers
CBD products can create THC testing risk because labeling, full-spectrum content, and contamination vary; employees in testing programs should not rely on marketing claims.
What This Means
CBD Drug Testing is an employer workflow topic involving workplace policy, occupational-health coordination, testing procedures, documentation, confidentiality, and legal review for Florida employers.
What Employers Should Remember
- CBD products can create THC testing risk because labeling, full-spectrum content, and contamination vary; employees in testing programs should not rely on marketing claims.
- Employers should distinguish DOT and non-DOT requirements before ordering tests or making decisions.
- Written policy, consistent documentation, MRO review where applicable, and qualified legal review reduce avoidable risk.
CBD Product Types and Testing Risk
| Product claim | Why employers should be careful | Policy message |
|---|---|---|
| Full-spectrum CBD | May contain THC. | Product labels do not guarantee a negative test. |
| CBD isolate | Labeling and contamination can vary. | Testing policy controls workplace expectations. |
| DOT-regulated worker | DOT has warned CBD use can create risk. | Do not rely on marketing claims. |
CBD product labels do not guarantee a negative test
CBD products vary widely. Full-spectrum products, mislabeled products, and contaminated products may contain THC. Employees subject to testing should not assume marketing language will protect them from a positive result.
Drug testing generally looks for THC metabolites, not the retail product source. A result may not show whether exposure came from CBD, marijuana, Delta-8, THCA, or another product.
Employer policies should avoid product-specific loopholes
Employers can reduce confusion by explaining that product labels, store legality, or claims such as hemp-derived do not override workplace policy or DOT requirements.
When employees raise CBD use after a non-negative result, employers should follow the defined review process, protect confidentiality, and involve the MRO or appropriate reviewer when applicable.
DOT-regulated workers should be especially cautious
DOT agencies have warned that CBD use can create risk for regulated employees. Employers should direct DOT-regulated employees to official federal guidance rather than informal product claims.
Turn This Guidance Into a Repeatable Workflow
Set up drug testing, DOT workflows, injury documentation, and occupational-health services through one employer-focused partner.
Suggested Steps
- Identify the employee group or role.
- Review the written policy.
- Confirm DOT or non-DOT status.
- Document the relevant facts.
- Use the defined testing and MRO workflow.
- Have counsel review close employment decisions.
Employer Checklist
- CBD warning included in policy
- DOT CBD risk communicated
- MRO workflow confirmed
- Employee education drafted
- Product-label loopholes avoided
Employer Takeaway
CBD Drug Testing should be handled as a documented employer workflow, not a one-off reaction. Castellan Health can support the occupational-health and testing process while employment counsel reviews policy and disciplinary decisions.
Sources to Verify Against Current Guidance
Use official sources for final policy review. Castellan Health provides occupational-health and testing information, not legal advice.